NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION

Ph.D

Saved in:
Bibliographic Details
Main Author: WONG LING RONG
Other Authors: PHARMACY
Format: Theses and Dissertations
Language:English
Published: 2019
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/151086
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-151086
record_format dspace
spelling sg-nus-scholar.10635-1510862024-10-24T18:08:45Z NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION WONG LING RONG PHARMACY Chi Lui Paul Ho Alzheimer's disease, mitochondria, intranasal drug delivery, nanoparticles, flurbiprofen, pioglitazone Ph.D DOCTOR OF PHILOSOPHY (FOS) 2019-01-21T18:00:23Z 2019-01-21T18:00:23Z 2018-08-17 Thesis WONG LING RONG (2018-08-17). NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION. ScholarBank@NUS Repository. http://scholarbank.nus.edu.sg/handle/10635/151086 0000-0002-3122-5857 en
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Alzheimer's disease, mitochondria, intranasal drug delivery, nanoparticles, flurbiprofen, pioglitazone
spellingShingle Alzheimer's disease, mitochondria, intranasal drug delivery, nanoparticles, flurbiprofen, pioglitazone
WONG LING RONG
NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION
description Ph.D
author2 PHARMACY
author_facet PHARMACY
WONG LING RONG
format Theses and Dissertations
author WONG LING RONG
author_sort WONG LING RONG
title NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION
title_short NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION
title_full NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION
title_fullStr NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION
title_full_unstemmed NOSE-TO-BRAIN DELIVERY OF MITOCHONDRIA TARGETING DRUGS FOR THE TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETIC AND NEUROPHENOTYPING EVALUATION
title_sort nose-to-brain delivery of mitochondria targeting drugs for the treatment of alzheimer's disease: pharmacokinetic and neurophenotyping evaluation
publishDate 2019
url http://scholarbank.nus.edu.sg/handle/10635/151086
_version_ 1821229419216240640